Lin A M, Freund R K, Hoffer B J, Palmer M R
Department of Pharmacology, University of Colorado Health Sciences Center, Denver.
J Pharmacol Exp Ther. 1994 Dec;271(3):1175-80.
Electrophysiological studies indicate that EtOH decreases the firing rate of cerebellar Purkinje neurons in vivo and in vitro through a GABAA mechanism. These neurons receive a prominent noradrenergic input from the locus coeruleus. Stimulation of the locus coeruleus or local application of beta-adrenergic agonists potentiates Purkinje neuron responses to GABA and sensitizes GABA responses to the potentiative effects of EtOH. In the present study, we found that the modulatory influences of the beta-adrenergic agonist isoproterenol potentiated EtOH-induced depressions of Purkinje neuron firing. This isoproterenol interaction with EtOH was antagonized by the beta-adrenergic antagonist timolol. We found evidence that endogenous catecholamines can cause this effect as well. Timolol antagonized EtOH-induced depressions on 20% of the neurons studied. This was the same frequency as that previously found for EtOH-induced potentiations of GABA depressions in this brain area. These data suggest that the Purkinje neurons showing this interaction receive spontaneously active catecholamine inputs that sensitize the GABA effects to the potentiative effects of ethanol. Consistent with this hypothesis, we also found that timolol antagonized this GABA/EtOH interaction. Taken together, these results are consistent with the hypothesis that EtOH-induced depressions of Purkinje neurons involved endogenous GABA actions that may be regulated by beta-adrenergic mechanisms.
电生理研究表明,乙醇在体内和体外通过GABAA机制降低小脑浦肯野神经元的放电频率。这些神经元从蓝斑接受显著的去甲肾上腺素能输入。刺激蓝斑或局部应用β-肾上腺素能激动剂可增强浦肯野神经元对GABA的反应,并使GABA反应对乙醇的增强作用敏感。在本研究中,我们发现β-肾上腺素能激动剂异丙肾上腺素的调节作用增强了乙醇诱导的浦肯野神经元放电抑制。异丙肾上腺素与乙醇的这种相互作用被β-肾上腺素能拮抗剂噻吗洛尔拮抗。我们发现有证据表明内源性儿茶酚胺也能引起这种效应。噻吗洛尔拮抗了乙醇对20%所研究神经元的诱导性抑制。这一频率与先前在该脑区发现的乙醇诱导的GABA抑制增强频率相同。这些数据表明,表现出这种相互作用的浦肯野神经元接受自发活动的儿茶酚胺输入,使GABA效应对乙醇的增强作用敏感。与这一假设一致,我们还发现噻吗洛尔拮抗了这种GABA/乙醇相互作用。综上所述,这些结果与以下假设一致,即乙醇诱导的浦肯野神经元抑制涉及内源性GABA作用,可能受β-肾上腺素能机制调节。